CRP and COVID-19: Second, frailty involving the process of complex chronic inflammation and proinflammatory cytokines, such as C-reactive protein, tumor necrosis factor (TNF)-a, interleukin (IL) or interleukin-6, exacerbates the risk of mortality when patients contract COVID-19 [35].